| CVSCX | CVSIX | CVSCX / CVSIX | |
| Total Expense Ratio | 1.97 | 1.22 | 161% |
| Annual Report Gross Expense Ratio | 1.97 | 1.22 | 161% |
| Fund Existence | 26 years | 35 years | - |
| Gain YTD | 5.168 | 5.775 | 89% |
| Front Load | N/A | 3% | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 16.9B | 16.9B | 100% |
| Annual Yield % from dividends | 0.91 | 1.57 | 58% |
| Returns for 1 year | 5.17 | 5.78 | 89% |
| Returns for 3 years | 16.82 | 19.19 | 88% |
| Returns for 5 years | 14.82 | 18.56 | 80% |
| Returns for 10 years | 29.08 | 38.31 | 76% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBBQ | 29.09 | 0.25 | +0.88% |
| Invesco Nasdaq Biotechnology ETF | |||
| BGDV | 27.69 | 0.11 | +0.40% |
| Bahl & Gaynor Dividend ETF | |||
| BSCV | 16.70 | 0.04 | +0.24% |
| Invesco BulletShares 2031 Corp Bd ETF | |||
| DMAY | 45.30 | 0.06 | +0.14% |
| FT Vest US Equity Deep Bffr ETF May | |||
| BUFH | 20.86 | 0.01 | +0.05% |
| FT Vest Laddered Max Buffer ETF | |||